Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04299308 · ClinicalTrials.gov registry record · NA

Acute Exercise and the Cerebral Metabolic Response in Aging and Alzheimer's Disease

A NA study of Alzheimer Disease and Healthy Aging, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04299308 is a NA study of Alzheimer Disease and Healthy Aging that has completed, run by University of Kansas Medical Center. The registered enrollment target is 60 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04299308, a NA study of Alzheimer Disease and Healthy Aging, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The overall goal is to characterize the acute exercise response as it relates to brain glucose metabolism in aging and Alzheimer's Disease (AD). The study team will also examine lactate metabolism, relationships with cognition, and the effect of exercise intensity.

Interventions

  • BEHAVIORAL Aerobic Exercise

Study Locations (1)

Kansas

  • Univeristy of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-08-28
Est. Completion 2023-10-31
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT04299308

The ClinicalTrials.gov registry entry for NCT04299308 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Aerobic Exercise is the first listed.

NCT04299308 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT04299308 about?

NCT04299308 is a clinical study titled "Acute Exercise and the Cerebral Metabolic Response in Aging and Alzheimer's Disease". The overall goal is to characterize the acute exercise response as it relates to brain glucose metabolism in aging and Alzheimer's Disease (AD). The study team will also examine lactate metabolism, relationships with cognition, and the effect of exercise intensity.

What is the current status of trial NCT04299308?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-08-28. Estimated completion is 2023-10-31.

What conditions does trial NCT04299308 study?

This clinical trial studies the following conditions: Alzheimer Disease, Healthy Aging.

What interventions are being tested in trial NCT04299308?

The interventions under investigation include: Aerobic Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT04299308?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04299308 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.